https://www.selleckchem.com/pr....oducts/monomethyl-au
Buprenorphine is an essential medication for the treatment of opioid use disorder (OUD), but studies show it has been underused over the last 2 decades. We sought to evaluate utilization of and spending on buprenorphine formulations in Medicaid and to evaluate the impact of key market and regulatory factors affecting availability of different formulations and generic versions. We first identified all buprenorphine formulations approved by the Food and Drug Administration for OUD using Drugs@FDA. We then used Nationa
Gefällt mir
Kommentar
Teilen
